 Equities analysts forecast that NeoGenomics, Inc. NASDAQ:NEO will post 128.91 million in sales for the current fiscal quarter, according to Zacks Investment Research. Three analysts have provided estimates for NeoGenomics earnings, with estimates ranging from 128.36 million to 130.00 million. NeoGenomics reported sales of 104.67 million in the same quarter last year, which indicates a ... 